Home Compare LLY vs ORNBV.HE
Stock Comparison · Industry comparison · Drug Manufacturers - General

Eli Lilly and Company vs Orion Oyj: Which Stock Looks Stronger in 2026?

Orion Oyj holds the cleaner structural position, with stability as the main driver and valuation adding further support. Eli Lilly and Company does not offset that deficit through any equally strong structural edge elsewhere. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both stability and valuation materially support the lead. Orion Oyj leads by 15 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Drug Manufacturers - General

This comparison is based on industry proximity, not on functional trajectory similarity. LLY and ORNBV.HE share the same industry classification.

For a similarity-based comparison, see how Eli Lilly and Company and Orion Oyj each position within their functional peer groups in AssetNext.

Peer-Relative Score
LLY
Eli Lilly and Company
68
Peer-Score
Signal qualityHigh
vs
ORNBV.HE
Orion Oyj
83
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: LLY vs ORNBV.HE Profitability 100 100 Stability 34 71 Valuation 44 61 Growth 88 100 LLY ORNBV.HE
Gap Ranking
#1 Stability +37
#2 Valuation +17
#3 Growth +12
#4 Profitability
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for LLY and ORNBV.HE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer LLYORNBV.HE Relative valuation Structural strength

Orion Oyj looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Orion Oyj ranks near the top of the group on stability; Eli Lilly and Company sits in the weaker half.
Valuation
On valuation, the same pattern holds: both rank well, but Orion Oyj still sits higher.
Stability — Dominant Gap
LLY
34
ORNBV.HE
71
Gap+37in favour of ORNBV.HE

The clearest distance comes from a steadier profile over time.

What else supports the lead

A forward P/E that is 5.1 turns lower adds a second meaningful layer to the lead.

What this means for the comparison

Stability is the clearest driver, and valuation also supports Orion Oyj's broader structural position.

Explore full peer positioning in AssetNext

Break down the LLY vs ORNBV.HE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how LLY and ORNBV.HE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.